The effectiveness and impact of the enterovirus 71 vaccine on the onset of hand, foot, and mouth disease in children aged ≤5 years: A 7-year study - 17/09/24
Doi : 10.1016/j.jinf.2024.106244
Chenlu Fan a, b, Yingying Yang c, Siyi Zhan d, Xiu Sun e, Chuanxi Fu a, b, ⁎ 
a The Institute of Infectious Disease and Vaccine, School of Public Health, Zhejiang Chinese Medical University, No.548, Binwen Rd, Hangzhou, 310053, China
b Center for Vaccine Impact Assessment, Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Prodcuts, National Medical Products Administration, No.548, Benwen Rd, Hangzhou, 310053, China
c Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention, Hangzhou, 310021, China
d Zhejiang Provincial People's Hospital, Hangzhou, 314408, China
e The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou,310009, China
⁎Corresponding author at: The Institute of Infectious Disease and Vaccine, School of Public Health, Zhejiang Chinese Medical University, No.548, Binwen Rd, Hangzhou, 310053, China.The Institute of Infectious Disease and Vaccine, School of Public Health, Zhejiang Chinese Medical UniversityNo.548, Binwen RdHangzhou310053China
Le texte complet de cet article est disponible en PDF.
Plan
© 2024
The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 89 - N° 4
Article 106244- octobre 2024 Retour au numéro
Article précédent
- ‘Bloodstream infection’: A valuable concept we should keep in our toolbox
- Anders Skyrud Danielsen, Qingze Gu, Aasmund Fostervold, David W. Eyre, Jørgen Vildershøj Bjørnholt
- Looming threat of Mpox in Pakistan: Time to take urgent measures
- Massab Umair, Muhammad Salman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?